Anatomy of a Biotech Failure: Part II

learning from the lessons of the graveyard

Sep 3 • 

age1

 and 

Soleil Wizman

21

1

August 2025

Anatomy of a Biotech Failure: Part I

Eight Case Studies in Recent Shutdown History

Aug 28 • 

age1

 and 

Soleil Wizman

52

July 2025

age1’s 2025 1st Annual Pharma Aging Report Card

Grading the giants on their race to extend human healthspan

Jul 29 • 

age1

 and 

Soleil Wizman

26

Is this aging?

So you wanna build an aging company?

Jul 3 • 

Sarah Constantin

, 

Lily Clayton

, and 

age1

22

3

March 2024

A call to arms to save the genome

How protecting our genetic code can turn the tide against death

Mar 28, 2024 • 

age1

 and 

Alan Tomusiak

17

What we wish we knew entering the aging field

The longevity funnel framework (LFF)

Mar 14, 2024 • 

age1

 and 

Maggie Li

30

February 2024

A guide to extend longevity by delaying menopause

Refusing menopause as an inevitable truth

Feb 19, 2024 • 

age1

 and 

Carol Magalhaes

19

December 2023

Dear Founders: age1’s 2024 wishlist for new companies to unlock healthy longevity for all

We want exceptional founders to work on achieving healthy lifespan extension within the next decade.

Dec 30, 2023 • 

age1

3

$200 Billion in Revenue: How an Aging Drug Will Conquer Pharma

An aging drug is a drug that has been rigorously shown to increase healthy lifespan in people, with emphasis on the ability to extend quality of life…

Dec 8, 2023 • 

age1

22

September 2023

age1's vision

We fund healthy lifespan extension

Sep 19, 2023

29